Extracorporeal Membrane Oxygenation in Refractory Cardiac Arrest: Current Evidence, Clinical Pathways and Future Directions
Life · 21.05.2026 · 16 (5) · 857
DOI: 10.3390/life16050857 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.05.2026. Verfasst von Debora Emanuela Torre und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Anesthesia and Intensive Care Unit, Cardiac Surgery, Ospedale Dell'Angelo, 30174 Venice, Italy. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Reanimation
Abstract (Originalsprache)
Background
Extracorporeal cardiopulmonary resuscitation (ECPR) has emerged as a promising strategy for refractory cardiac arrest, enabling the restoration of systemic perfusion when conventional resuscitation fails. However, uncertainties remain regarding patient selection, timing and implementation.
Methods
A narrative review of experimental data, clinical studies, randomized trials and international recommendations was performed. Particular emphasis was placed on the interplay between physiological mechanisms, real-world organizational models and decision-making processes.
Results
ECPR can restore effective circulation, preserve end organ perfusion and serve as a bridge to definitive etiologic treatment, with the potential to improve survival and neurological outcomes in highly selected patients. However, its effectiveness is strongly dependent on rapid deployment, structured systems of care and multidisciplinary coordination. Significant challenges remain, including in relation to the heterogeneity of protocols, high resource utilization, complications with extracorporeal support and the complexity of post-resuscitation management. Furthermore, ECPR fundamentally alters traditional resuscitation paradigms, introducing ethical dilemmas related to patient selection, prognostication and the allocation of limited resources.
Conclusions
ECPR represents a transition from procedure-based resuscitation to system-based extracorporeal support. Its clinical benefit is contingent upon timely implementation within optimized organizational frameworks and integration with definitive treatment pathways. Future research should focus on refining selection criteria, standardizing care pathways and addressing ethical sustainability challenges to ensure appropriate and effective use of this evolving technology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Anesthesia and Intensive Care Unit, Cardiac Surgery, Ospedale Dell'Angelo, 30174 Venice, Italy.
- Cardiac Surgery Department, Ospedale Dell'Angelo, 30174 Venice, Italy.
- Department of Neurosciences, Institute of Human Anatomy, University of Padova, 35121 Padua, Italy.
ORCID-Profile: Debora Emanuela Torre, Carmelo Pirri
Zitieren
APA
Torre, D. E., Mangino, D., & Pirri, C. (2026). Extracorporeal Membrane Oxygenation in Refractory Cardiac Arrest: Current Evidence, Clinical Pathways and Future Directions. Life, 16(5), 857. https://doi.org/10.3390/life16050857
Vancouver
Torre DE, Mangino D, Pirri C. Extracorporeal Membrane Oxygenation in Refractory Cardiac Arrest: Current Evidence, Clinical Pathways and Future Directions. Life. 2026;16(5):857. doi:10.3390/life16050857
BibTeX
@article{Torre2026,
author = {Torre, Debora Emanuela and Mangino, Domenico and Pirri, Carmelo},
title = {Extracorporeal Membrane Oxygenation in Refractory Cardiac Arrest: Current Evidence, Clinical Pathways and Future Directions},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {857},
doi = {10.3390/life16050857}
}
EUVIMED